Randomized Controlled Trial Testing Mobile-Based Attention-Bias Modification for Posttraumatic Stress Using Personalized Word Stimuli.
Andrea Nicole NilesJoshua D WoolleyPaige TrippAna PesquitaSophia VinogradovThomas C NeylanAoife O'DonovanPublished in: Clinical psychological science : a journal of the Association for Psychological Science (2020)
Although behavioral therapies are effective for posttraumatic stress disorder (PTSD), access for patients is limited. Attention-bias modification (ABM), a cognitive-training intervention designed to reduce attention bias for threat, can be broadly disseminated using technology. We remotely tested an ABM mobile app for PTSD. Participants (N = 689) were randomly assigned to personalized ABM, nonpersonalized ABM, or placebo training. ABM was a modified dot-probe paradigm delivered daily for 12 sessions. Personalized ABM included words selected using a recommender algorithm. Placebo included only neutral words. Primary outcomes (PTSD and anxiety) and secondary outcomes (depression and PTSD clusters) were collected at baseline, after training, and at 5-week-follow-up. Mechanisms assessed during treatment were attention bias and self-reported threat sensitivity. No group differences emerged on outcomes or attention bias. Nonpersonalized ABM showed greater declines in self-reported threat sensitivity than placebo (p = .044). This study constitutes the largest mobile-based trial of ABM to date. Findings do not support the effectiveness of mobile ABM for PTSD.
Keyphrases
- posttraumatic stress disorder
- randomized controlled trial
- working memory
- social support
- phase iii
- study protocol
- end stage renal disease
- systematic review
- clinical trial
- chronic kidney disease
- depressive symptoms
- sleep quality
- ejection fraction
- double blind
- prognostic factors
- newly diagnosed
- placebo controlled
- peritoneal dialysis
- quantum dots
- meta analyses